Health-tech and life sciences companies communicate under rules that other technology companies never meet. A claim about a product is also a claim about patients. A press release can move a share price or draw the attention of a regulator. And the audience includes doctors, hospital managers, insurers and investors, each of whom reads the same announcement differently.
This guide covers the Israeli sector in numbers, the rules that shape what can be said, and a practical plan for building a reputation, both for Israeli companies and for international health companies entering Israel.
- Israel has about 1,800 active life sciences companies employing about 81,000 people.
- Private investment in 2025 fell to its lowest level in five years, so every announcement has to work harder.
- In health, evidence is the story. Publish data, not adjectives.
- Clinical, regulatory and commercial milestones each need a different message and a different outlet.
The sector in numbers
The annual report by the Israel Advanced Technology Industries association, the Israel Innovation Authority and PwC Israel describes a stable but under-funded sector. The number of active companies held steady, exports were unchanged, and large acquisitions continued, while private fundraising fell to a five-year low.
For communications the conclusion is practical. When money is scarce, investors and partners look harder at credibility. Companies that have built a record of accurate, evidence-based announcements find it easier to raise funds and sign partners than those that appear in the press only when they need something.
What makes health PR different
Milestones that make news
The rules of careful language
- Say what the study showed, not what you hope the product will do.
- Give the number of participants and the stage of the trial.
- Separate cleared uses from uses still under investigation.
- Avoid words such as cure, breakthrough and revolutionary unless an independent authority has used them.
- Have every release reviewed by the medical and regulatory leads, and by legal counsel if the company is listed.
- Never use patient stories without written consent and a clear explanation of how they will be published.
A plan for the quiet periods
Between milestones a health company may have nothing to announce for a year or more. This is when reputations are built or lost. The tools are different from news announcements.
International health companies entering Israel
Israel is attractive for health companies because of its digitised health records, four national health funds and concentrated hospital system. For a company arriving from abroad, the first communications questions are local: which health fund or hospital is the partner, what will Israeli patients gain, and who speaks for the company in Hebrew. A local partner named in the announcement is the strongest signal of commitment. Our playbook for entering the Israeli market and the page on PR in Israel for international companies cover the wider process.
Related guides: the Israeli media landscape, how to announce a funding round and PR for AI visibility.
Our service: Health-tech and life sciences PR agency in Israel
Frequently asked questions
Can we announce early trial results?
Yes, if the announcement states clearly the stage of the trial, the number of participants and the limits of the findings. Overstating early data damages credibility with journalists, investors and regulators.
Who should speak for a health company?
The founder for the business story and a clinician or scientist for the medical story. Journalists covering health expect to speak to someone who can answer clinical questions.
Is it harder to get coverage in a weak funding market?
Funding news is rarer, so companies need other stories: data, partnerships, expert commentary and clinical milestones.
Do we need separate Hebrew and English communications?
Usually yes. Israeli media and the health system respond to local partners and local benefit, while international media look for market size, evidence and regulatory status.
How do regulatory rules affect a press release?
Claims about a medical product must match what the regulator has cleared. Uses under investigation must be described as such.
Creativity Value is a local PR agency for startups and international companies entering the Israeli market.
